BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51
2406 results:

  • 1. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
    Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.
    Deng Q; Lakra P; Gou P; Yang H; Meydan C; Teater M; Chin C; Zhang W; Dinh T; Hussein U; Li X; Rojas E; Liu W; Reville PK; Kizhakeyil A; Barisic D; Parsons S; Wilson A; Henderson J; Scull B; Gurumurthy C; Vega F; Chadburn A; Cuglievan B; El-Mallawany NK; Allen C; Mason C; Melnick A; Green MR
    Cancer Cell; 2024 Apr; 42(4):605-622.e11. PubMed ID: 38458188
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. bcl6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.
    Chen D; Zhao HM; Deng XH; Li SP; Zhou MH; Wu YX; Tong Y; Yu RQ; Pang QF
    Exp Lung Res; 2024; 50(1):25-41. PubMed ID: 38419581
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell lymphoma and Clinical Significance].
    Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Describing patterns of familial cancer risk in subfertile men using population pedigree data.
    Ramsay JM; Madsen MJ; Horns JJ; Hanson HA; Camp NJ; Emery BR; Aston KI; Ferlic E; Hotaling JM
    Hum Reprod; 2024 Apr; 39(4):822-833. PubMed ID: 38383051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
    Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
    Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Next Generation Sequencing Analysis of Fibrin-associated Large B-cell lymphoma Reveals Pathogenic Single Nucleotide Variants.
    DO J; Yenwongfai LN; DO SI; Na K
    Anticancer Res; 2024 Feb; 44(2):665-672. PubMed ID: 38307569
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An atlas of cells in the human tonsil.
    Massoni-Badosa R; Aguilar-Fernández S; Nieto JC; Soler-Vila P; Elosua-Bayes M; Marchese D; Kulis M; Vilas-Zornoza A; Bühler MM; Rashmi S; Alsinet C; Caratù G; Moutinho C; Ruiz S; Lorden P; Lunazzi G; Colomer D; Frigola G; Blevins W; Romero-Rivero L; Jiménez-Martínez V; Vidal A; Mateos-Jaimez J; Maiques-Diaz A; Ovejero S; Moreaux J; Palomino S; Gomez-Cabrero D; Agirre X; Weniger MA; King HW; Garner LC; Marini F; Cervera-Paz FJ; Baptista PM; Vilaseca I; Rosales C; Ruiz-Gaspà S; Talks B; Sidhpura K; Pascual-Reguant A; Hauser AE; Haniffa M; Prosper F; Küppers R; Gut IG; Campo E; Martin-Subero JI; Heyn H
    Immunity; 2024 Feb; 57(2):379-399.e18. PubMed ID: 38301653
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
    Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
    Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses.
    Scherlinger M; Li H; Pan W; Li W; Karino K; Vichos T; Boulougoura A; Yoshida N; Tsokos MG; Tsokos GC
    Nat Commun; 2024 Jan; 15(1):840. PubMed ID: 38287012
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
    Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
    Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Delineating the mechanism of fragility at bcl6 breakpoint region associated with translocations in diffuse large B cell lymphoma.
    Gopalakrishnan V; Roy U; Srivastava S; Kariya KM; Sharma S; Javedakar SM; Choudhary B; Raghavan SC
    Cell Mol Life Sci; 2024 Jan; 81(1):21. PubMed ID: 38196006
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 15. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.
    Zhang C; Stelloo E; Barrans S; Cucco F; Jiang D; Tzioni MM; Chen Z; Li Y; Swennenhuis JF; Makker J; Rásó-Barnett L; Liu H; El-Daly H; Soilleux E; Shah N; Nagumantry SK; Kyaw M; Prahladan MP; Tooze R; Westhead DR; Feitsma H; Davies AJ; Burton C; Johnson PWM; Du MQ
    Leukemia; 2024 Mar; 38(3):621-629. PubMed ID: 38184753
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
    Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L;
    J Pathol; 2024 Mar; 262(3):255-270. PubMed ID: 38180354
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Follicular lymphoma with a predominantly diffuse growth pattern with 1p36 deletion: a clinicopathologic analysis of eight cases].
    Zhou J; Xie JL; Zhou XG; Zhou XJ; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):34-39. PubMed ID: 38178744
    [No Abstract]    [Full Text] [Related]  

  • 18. A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma.
    de Jonge AV; Bult JAA; Karssing DFE; Nijland M; Chamuleau MED; Brink M
    Blood Cancer J; 2024 Jan; 14(1):2. PubMed ID: 38177113
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
    Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
    J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Oral follicular lymphoma: a clinicopathologic and molecular study.
    Souza LL; Cáceres CVBL; Sant'Ana MSP; Penafort PVM; Andrade BAB; Pontes HAR; Castro WH; Mesquita RA; Xavier-Júnior JCC; Santos-Silva AR; Lopes MA; Soares CD; Robinson L; van Heerden WFP; Burbano RMR; Assis-Mendonça GR; Vassallo J; Sousa SF; Vargas PA; Fonseca FP
    J Hematop; 2023 Dec; 16(4):199-208. PubMed ID: 38175434
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 121.